[1]
Samura, B. 2019. Influence of atorvastatin therapy on biological markers and cardiovascular risk in patients with chronic lymphocytic leukemia in remission. Zaporozhye Medical Journal. 1 (Feb. 2019). DOI:https://doi.org/10.14739/2310-1210.2019.1.155793.